Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins
Open Access
- 15 June 2002
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (12) , 6224-6234
- https://doi.org/10.1128/jvi.76.12.6224-6234.2002
Abstract
A critical event in papillomavirus transformation of human cells is the inactivation of pRB by the E7 protein. E7, like many other viral oncoproteins, possesses a well-characterized LXCXE peptide motif that interacts with the pocket domain of pRB. Disruption of the LXCXE-binding cleft on pRB renders it resistant to E7 binding and inactivation. Such binding cleft mutants of pRB are capable of inducing a G 1 arrest in the human papillomavirus 18-transformed HeLa cell line. We show here that the efficient inactivation of pRB in HeLa cells does not simply depend on the integrity of the LXCXE-binding cleft. Multiple site-directed mutants that alter conserved surfaces of the pRB pocket domain cause HeLa cells to accumulate in G 1 . We divide these mutants into two classes: those that can be bound by E7 and those that cannot. The E7 interacting mutants include changes in conserved residues that lie in a groove between the A and B halves of the pocket. Surprisingly, none of these mutants show a clear defect in any of the known mechanisms for pRB inactivation by E7. Analysis of mutants that are compromised for E7 binding reveals that this interaction depends on both the LXCXE-binding cleft and on a conserved group of lysines adjacent to the cleft. These basic amino acids on pRB define a discrete interaction point with E7. These residues most likely form ionic interactions with conserved acidic amino acids on E7 since a stable pRB/E7 interaction was restored when the lysine residues on pRB and the acidic residues on E7 were interchanged.Keywords
This publication has 43 references indexed in Scilit:
- Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma proteinOncogene, 2001
- Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cellsOncogene, 2001
- Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient To Overcome Cell Cycle Arrest in Human KeratinocytesJournal of Virology, 2001
- Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypesSeminars in Cancer Biology, 1999
- Cyclin E-induced S phase without activation of the pRb/E2F pathway.Genes & Development, 1997
- Cancer Cell CyclesScience, 1996
- The retinoblastoma protein and cell cycle controlCell, 1995
- The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene ProductScience, 1989
- Cellular targets for transformation by the adenovirus E1A proteinsCell, 1989
- The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1ACell, 1988